Intra-Cellular Therapies ITCI
$ 83.85
-0.35%
Quarterly report 2024-Q3
added 10-30-2024
Intra-Cellular Therapies General and Administrative Expenses 2011-2024 | ITCI
Annual General and Administrative Expenses Intra-Cellular Therapies
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
410 M | 359 M | 273 M | 186 M | 64.9 M | 30.1 M | 23.7 M | 24.8 M | 18.2 M | 10.3 M | - | 4.03 M | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
410 M | 4.03 M | 128 M |
Quarterly General and Administrative Expenses Intra-Cellular Therapies
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
132 M | 122 M | 113 M | - | 105 M | 101 M | 98.9 M | - | 88.4 M | 100 M | 75.5 M | - | 70.5 M | 69.9 M | 52.6 M | - | 52.5 M | 41.4 M | 34.1 M | - | 15 M | 15.4 M | 11.7 M | - | 7.97 M | 6.73 M | 6.38 M | - | 5.32 M | 6.25 M | 6.31 M | - | 6.27 M | 6.47 M | 5.06 M | - | 3.89 M | 3.99 M | 3.77 M | - | 2.58 M | 2.12 M | 1.91 M | - | 1.3 M | 903 K | 1.05 M | - | 802 K | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
132 M | 802 K | 37.3 M |